Brief: China Grand Pharmaceutical & Healthcare Says Tadalafil Tablets Granted Drug Registration Certificate
07/07/2021 11:19
July 7 (Reuters) - China Grand Pharmaceutical and Healthcare
Holdings Ltd 0512.HK :
* TADALAFIL TABLETS WAS GRANTED A DRUG REGISTRATION
CERTIFICATE
* TADALAFIL TABLETS GRANTED A DRUG REGISTRATION CERTIFICATE
BY
CHINA NMPA
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement